SRC and neoplasm: Recent evidence has indicated that FAT1 expressed by tumor cells can activate the Hippo pathway by serving as a scaffold to assemble several components of the Hippo signaling pathway10 and that FAT1 inhibits CAMK2-mediated nuclear translocation of YAP/TAZ through SRC/YES kinases13.